Preexposure to repeated low doses of zymosan increases the susceptibility to pulmonary infection in rats

Experimental Lung Research

Volumn 35, Issue 7, 2009, Pages 570-590

  Young, Shih Houng ^a   Antonini, James M ^a   Roberts, Jenny R ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

1 3 glucans; fungal infections; Listeria monocytogenes; lung inflammation; pulmonary clearance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN; AUTACOID; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MEGADOSE; EXPOSURE; INFECTION SENSITIVITY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LOW DRUG DOSE; LUNG FUNCTION; LUNG INFECTION; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RAT; TH1 CELL; TH2 CELL; ANIMAL; BACTERIAL COUNT; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LISTERIOSIS; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; TH1 CELLS; TH2 CELLS; ZYMOSAN;

EID: 75549087117     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140902763201     Document Type: Article

References (48)

1. Sahakian NM, Park JH, Cox-Ganser JM: Dampness and mold in the indoor environment: implications for asthma. Immunol Allergy Clin North Am. 2008;28:485-505.
2. Fung F, Hughson WG: The fundamentals of mold-related illness: when to suspect the environment is making a patient sick. Postgrad Med. 2008;120:80-84.
3. Brandt M, et al: Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR Recomm Rep. 2006;55(RR-8):1-27.
4. Weber S, et al: Organic dust exposures from compost handling: case presentation and respiratory exposure assessment. Am J Ind Med. 1993;24:365-374.
5. Allermann L, Poulsen OM: Inflammatory potential of dust from waste handling facilitiesmeasured as IL-8 secretion from lung epithelial cells in vitro. Ann Occup Hyg. 2000;44:259-269.
6. Palmberg L, et al: Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax. 1998;53:260-264.
7. Larsson BM, et al: Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid. Thorax. 1997;52:638-642.
8. Bachmann M, Myers JE: Grain dust and respiratory health in South African milling workers. Br J Ind Med. 1991;48:656-662.
9. Von Essen SG, et al: Mechanisms of neutrophil recruitment to the lung by grain dust exposure. Am Rev Respir Dis. 1988;138:921-927.
10. Rylander R: Airborne (1?3)-beta-d-glucan and airway disease in a day-care center before and after renovation. Arch Environ Health. 1997;52:281-285.
11. Thorn J, Rylander R: Airways inflammation and glucan in a rowhouse area. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1798-1803.
12. Thorn J, Beijer L, Rylander R: Airways inflammation and glucan exposure among household waste collectors. Am J Ind Med. 1998;33:463-470.
13. Rylander R, Thorn J, Attefors R: Airways inflammation among workers in a paper industry. Eur Respir J. 1999;13:1151-1157.
14. Rylander R: Health effects among workers in sewage treatment plants. Occup Environ Med. 1999;56:354-357.
15. Rylander R, Thorn T, Attefors R: Airways inflammation among workers in a paper industry. Eur Respir J. 1999;13:1151-1157.
16. Rylander R: Organic dusts and lung reactions-exposure characteristic and mechanisms for disease. Scand J Work Environ Health. 1985;11:199-206.
17. Rylander R, Jacobs RR: Organic Dust Exposure, Effects, and Prevention. Boca Raton, FL: CRC; 1994:299.
18. Young S-H, et al: Acute inflammation and recovery in rats after intratracheal instillation of a 1?3- beta-glucan (zymosan A). J Toxicol Environ Health A. 2001;64:311-325.
19. Young S-H, et al: A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J Toxicol Environ Health A. 2007;70:1116-1124.
20. Dales R, et al: Influence of residential fungal contamination on peripheral blood lymphocyte populations in children. Arch Environ Health. 1998;53:190-5.
21. Young S-H, Roberts JR, Antonini JM: Pulmonary exposure to 1?3-beta-glucan alters adaptive immune responses in rats. Inhal Toxicol. 2006;18:865-874.
22. Hirvonen MR, et al: Nitric oxide and proinflammatory cytokines in nasal lavage fluid associated with symptoms and exposure to moldy building microbes. Am J Respir Crit Care Med. 1999;160:1943-1946.
23. Korpi A, et al: Slight respiratory irritation but not inflammation in mice exposed to (1?3)-betad- glucan aerosols. Mediators Inflamm. 2003;12:139-146.
24. Young S-H, et al: Exposure to particulate 1?3-beta-glucans induces greater pulmonary toxicity than soluble 1?3-beta-glucans in rats. J Toxicol Environ Health A. 2003;66:25-38.
25. Bohn JA, BeMiller JN: (13)-beta-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydrate Polymers. 1995;28:3-14.
26. Fogelmark B, Sjostrand M, Rylander R: Pulmonary inflammation induced by repeated inhalations of beta-(1,3)-D-glucan and endotoxin. Int J Exp Pathol. 1994;75:85-90.
27. Harada T, Harada A: Curdlan and succinoglycan. In Dumitriu S, ed. Polysaccharides in Medical Applications. New York: Marcel Dekker; 1996:21-58.
28. Manners DJ, Masson AJ, Patterson JC: The structure of a beta-(1-3)-D-glucan from yeast cell walls. Biochem J. 1973;135:19-30.
29. Young S-H, Antonini J, Roberts JR: Single pre-exposure to a high dose of zymosan enhances lung defense mechanisms and accelerates the pulmonary clearance of a bacterial pathogen in rats. Exp Lung Res. 2008;34:559-578.
30. Antonini JM, Roberts JR, Clarke RW: Strain-related differences of nonspecific respiratory defense mechanisms in rats using a pulmonary infectivity model. Inhal Toxicol. 2001;13:85-102.
31. Castranova V, et al: Pulmonary response of guinea pigs to consecutive exposures to cotton dust. In Proceedings of the 14th Cotton Dust Research Conferences. Las Vegas, NV: National Cotton Council; 1990.
32. Southwick FS, Purich DL: Intracellular pathogenesis of listeriosis. N Engl J Med. 1996;334:770-776.
33. Shen H, Tato CM, Fan X: Listeria monocytogenes as a probe to study cell-mediated immunity. Curr Opin Immunol. 1998;10:450-458.
34. Portnoy DA, Auerbuch V, Glomski IJ: The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol. 2002;158:409-414.
35. Pamer EG: Immune responses to Listeria monocytogenes. Nat Rev Immunol. 2004;4:812-23.
36. Kadish JK, Choi CC, Czop JK: Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages. Immunol Res. 1986;5:129-138.
37. Daum T, Rohrbach MS: Zymosan induces selective release of arachidonic acid from rabbit alveolar macrophage via stimulation of a beta-glucan receptor. FEBS Lett. 1992;309:119-122.
38. Suzuki T, et al: Serum components induce beta-D-glucan-inhitable uptake of zymosan particles by murine peritoneal macrophages. Biol Pharmaceut Bull. 1993;16:223-227.
39. Dunn PL, North RJ: Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun. 1991;59:2892-2900.
40. Rogers HW, Unanue ER: Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun. 1993;61:5090-5096.
41. Borish L, et al: Activation of neutrophils by recombinant interleukin 6. Cell Immunol. 1989;121:280-289.
42. Busch DH, Pamer EG: T lymphocyte dynamics during Listeria monocytogenes infection. Immunol Lett. 1999;65:93-98.
43. Mosmann TR: T lymphocyte subsets, cytokines, and effector functions. Ann N Y Acad Sci. 1992;664:89-92.
44. Trinchieri G: Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol. 1998;70:83-243.
45. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251-276.
46. Park AY, Scott P: Il-12: keeping cell-mediated immunity alive. Scand J Immunol. 2001;53:529-532.
47. Berg RE, Cordes CJ, Forman J: Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol. 2002;32:2807-2816.
48. Neighbors M, et al: A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med. 2001;194:343-354.